1097-0142/asset/cover.gif?v=1&s=a7299bc18f075294c232ade468773cd0672bd470 "Cancer")
Fax: (212) 717-3214
1097-0142/asset/olbannerleft.gif?v=1&s=ca681f5719430b26e1bc15e9ea4c9fc0a7110104)
1097-0142/asset/olbannerright.gif?v=1&s=8142566facf7e76aef9be6c51162a2e920b3b9f9)
Original Article
You have full text access to this OnlineOpen article
The clinical significance of malignant pleural effusions in patients with optimally debulked ovarian carcinoma
Article first published online: 22 FEB 2005
DOI: 10.1002/cncr.20920
Copyright © 2005 American Cancer Society
Additional Information
How to Cite
Eitan, R., Levine, D. A., Abu-Rustum, N., Sonoda, Y., Huh, J. N., Franklin, C. C., Stevens, T. A., Barakat, R. R. and Chi, D. S. (2005), The clinical significance of malignant pleural effusions in patients with optimally debulked ovarian carcinoma. Cancer, 103: 1397–1401. doi: 10.1002/cncr.20920
- †
Fax: (212) 717-3214
Publication History
- Issue published online: 18 MAR 2005
- Article first published online: 22 FEB 2005
- Manuscript Revised: 3 DEC 2004
- Manuscript Accepted: 3 DEC 2004
- Manuscript Received: 21 JUL 2004
REFERENCES
- 1, , , et al. Cancer statistics, 2004. CA Cancer J Clin. 2004; 54: 8–29.
- 2[No authors listed.] FIGO annual report on the results of treatment in gynecologic cancer. J Epidemiol Biostat. 1998; 3: 76.
- 3
- 4, , , . Clinical course of Stage IV epithelial ovarian cancer. J Clin Oncol. 1999; 17: 3361–3362.
- 5, , , et al. Natural history of Stage IV epithelial ovarian cancer. J Clin Oncol. 1999; 17: 767–775.
- 6. Epithelial ovarian carcinoma: principles of primary surgery [review]. Gynecol Oncol. 1994; 55(3 Pt 2): S91–S96.
- 7, , , , . Survival effect of maximal cytoreductive surgery for advanced ovarian carcinoma during the platinum era: a meta-analysis. J Clin Oncol. 2002; 20: 1248–1259.
- 8, , , et al. Identification of prognostic factors in advanced epithelial ovarian carcinoma. Gynecol Oncol. 2001; 82: 532–537.
- 9, , , , . Stage IV ovarian cancer: impact of surgical debulking. Gynecol Oncol. 1997; 64: 9–12.
- 10, , , , , . Effect of surgical debulking on survival in Stage IV ovarian cancer. Gynecol Oncol. 1997; 64: 4–8.
- 11, , , et al. Prognostic significance of residual disease in patients with Stage IV epithelial ovarian cancer. Gynecol Oncol. 1997; 64: 13–17.
- 12, , , , . Survival impact of surgical cytoreduction in Stage IV epithelial ovarian cancer. Gynecol Oncol. 1999; 72: 278–287.
- 13, , , , , . Optimal cytoreductive surgery is an independent prognostic indicator in Stage IV epithelial ovarian cancer with hepatic metastases. Gynecol Oncol. 2000; 78: 171–175.
- 14International Federation of Gynecology and Obstetrics (FIGO) Cancer Committee. Staging announcement. Gynecol Oncol. 1986; 25: 383–385.
- 15, , . Current management of epithelial ovarian carcinoma: a review. Semin Surg Oncol. 2000; 19: 11–19.
- 16, , , et al. Improved optimal cytoreduction rates for Stage IIIC and IV epithelial ovarian, fallopian tube, and primary peritoneal carcinoma: a change in surgical approach. Gynecol Oncol. 2004; 94: 650–654.
- 17, , , et al. The benefit of video-assisted thoracoscopic surgery (VATS) prior to planned abdominal exploration in patients with suspected advanced ovarian cancer and moderate to large pleural effusions. Gynecol Oncol. 2004; 94: 307–311.
- 18. Thoracoscopy for the management of advanced epithelial ovarian cancer—a preliminary report. Gynecol Oncol. 2002; 84: 315–320.
- 19, , , et al. Neoadjuvant chemotherapy followed by tumor debulking prolongs survival for patients with poor prognosis in International Federation of Gynecology and Obstetrics Stage IIIC ovarian carcinoma. Cancer. 2001; 92: 2585–2591.
- 20, , , , , . Neoadjuvant chemotherapy of primary debulking surgery in advanced ovarian carcinoma: a retrospective analysis of 285 patients. Gynecol Oncol. 1998; 71: 431–436.
- 21, , , , . Neoadjuvant chemotherapy for advanced ovarian cancer: long-term survival. Gynecol Oncol. 1999; 72: 93–99.